What will be the price of Besudil in 2025? Has there been a change from the current price?

Belumosudil (Belumosudil) is a drug targeting rejection and autoimmune diseases. In recent years, it has achieved remarkable results in the treatment of chronic graft-versus-host disease (cGVHD). With the launch of Besudil in China and its inclusion in medical insurance, patients can obtain the drug through medical insurance reimbursement. However, due to the high price of its original drugs, many patients still face a heavy financial burden.

By2025, the price of besudil may change to some extent, especially as medical insurance coverage expands and market competition intensifies. According to current price information, the original drug of Besudil is priced at approximately RMB 10,000 to 20,000 in the domestic market. Although this drug has been included in medical insurance, the actual payment amount after medical insurance reimbursement will vary by region. You need to consult the local hospital pharmacy for specific prices. It is expected that with the further improvement of medical insurance policies, patients' out-of-pocket expenses may be reduced, but drug prices will remain relatively high overall.

Besudil has been included in the scope of medical insurance reimbursement, which is a huge help to patients. According to the medical insurance policies in different regions, the reimbursement ratio may be different. Usually, after medical insurance reimbursement, the patient's out-of-pocket expenses will range from several thousand yuan to ten thousand yuan. For example, in some areas where the medical insurance reimbursement ratio is high, patients may only have to pay a few thousand yuan, while in areas where the reimbursement ratio is low, the out-of-pocket amount may be higher. In the future, with the further improvement and expansion of medical insurance policies, the burden on patients may be further reduced, especially for patients with more difficult financial conditions.

The high price of Besudil has prompted the emergence of overseas generic drugs, especially in some low-income countries, where the price of generic drugs is much lower than that of the original drug. For example, the price of the generic version of Besudil in countries such as Laos is only around 4,000 yuan, which is much lower than the price of the original drug. The launch of these generic drugs makes the drugs more affordable for more patients, especially in developing countries or areas without medical insurance support. However, although generic drugs are cheaper, patients still need to choose whether to use generic drugs under the guidance of their doctors.

Reference materials:https://www.rezuomib.com/